These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9820230

  • 21. Localization of endothelin-converting enzyme in bovine optic nerve and retina.
    Dibas A, Prasanna G, Yorio T.
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):288-97. PubMed ID: 16117692
    [Abstract] [Full Text] [Related]

  • 22. Characterization of endothelin-converting enzyme activities in ARPE-19 cells, a human retinal pigmented epithelial cell line.
    Dibas A, Prasanna G, Yorio T.
    J Ocul Pharmacol Ther; 2005 Jun; 21(3):196-204. PubMed ID: 15969636
    [Abstract] [Full Text] [Related]

  • 23. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis.
    Grantham JA, Schirger JA, Wennberg PW, Sandberg S, Heublein DM, Subkowski T, Burnett JC.
    Circulation; 2000 Apr 25; 101(16):1976-81. PubMed ID: 10779465
    [Abstract] [Full Text] [Related]

  • 24. Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.
    Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V.
    J Med Chem; 2010 Jan 14; 53(1):208-20. PubMed ID: 19899765
    [Abstract] [Full Text] [Related]

  • 25. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme.
    Claing A, Neugebauer W, Yano M, Rae GA, D'Orléans-Juste P.
    J Cardiovasc Pharmacol; 1995 Jan 14; 26 Suppl 3():S72-4. PubMed ID: 8587472
    [Abstract] [Full Text] [Related]

  • 26. Protective effects of a dual endothelin converting enzyme/neutral endopeptidase inhibitor on the development of pulmonary hypertension secondary to cardiac dysfunction in the rat.
    Dai ZK, Hsieh CC, Chai CY, Wu JR, Jeng AY, Chou SH, Wu BN, Yeh JL, Chen IJ, Tan MS.
    Pediatr Pulmonol; 2010 Nov 14; 45(11):1076-85. PubMed ID: 20658482
    [Abstract] [Full Text] [Related]

  • 27. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
    Yap EY, Battistini B, McKay KO.
    Br J Pharmacol; 2000 Jan 14; 129(1):170-6. PubMed ID: 10694217
    [Abstract] [Full Text] [Related]

  • 28. Design and synthesis of a potent and selective endothelin-converting enzyme inhibitor, CGS 35066.
    Jeng AY, De Lombaert S, Beil ME, Bruseo CW, Savage P, Chou M, Trapani AJ.
    J Cardiovasc Pharmacol; 2000 Nov 14; 36(5 Suppl 1):S36-9. PubMed ID: 11078330
    [Abstract] [Full Text] [Related]

  • 29. Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung.
    Shiosaki K, Tasker AS, Sullivan GM, Sorensen BK, von Geldern TW, Wu-Wong JR, Marselle CA, Opgenorth TJ.
    J Med Chem; 1993 Feb 19; 36(4):468-78. PubMed ID: 8474103
    [Abstract] [Full Text] [Related]

  • 30. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
    Trapani AJ, Beil ME, Bruseo CW, Fink CA, Hoyer D, Savage P, Jeng AY.
    Clin Sci (Lond); 2002 Aug 19; 103 Suppl 48():102S-106S. PubMed ID: 12193065
    [Abstract] [Full Text] [Related]

  • 31. WS75624 A and B, new endothelin converting enzyme inhibitors isolated from Saccharothrix sp. No. 75624. II. Structure elucidation of WS75624 A and B.
    Yoshimura S, Tsurumi Y, Takase S, Okuhara M.
    J Antibiot (Tokyo); 1995 Oct 19; 48(10):1073-5. PubMed ID: 7490209
    [Abstract] [Full Text] [Related]

  • 32. Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action.
    De Lombaert S, Blanchard L, Stamford LB, Tan J, Wallace EM, Satoh Y, Fitt J, Hoyer D, Simonsbergen D, Moliterni J, Marcopoulos N, Savage P, Chou M, Trapani AJ, Jeng AY.
    J Med Chem; 2000 Feb 10; 43(3):488-504. PubMed ID: 10669576
    [Abstract] [Full Text] [Related]

  • 33. Role of endothelin-converting enzyme, chymase and neutral endopeptidase in the processing of big ET-1, ET-1(1-21) and ET-1(1-31) in the trachea of allergic mice.
    De Campo BA, Goldie RG, Jeng AY, Henry PJ.
    Clin Sci (Lond); 2002 Aug 10; 103 Suppl 48():353S-356S. PubMed ID: 12193121
    [Abstract] [Full Text] [Related]

  • 34. Modulation of endothelin production and metabolism in guinea-pig tracheal epithelial cells by peptidase inhibitors.
    Yang Q, Battistini B, D'Orléans-Juste P, Jeng AY, Sirois P.
    Am J Respir Crit Care Med; 1997 Jun 10; 155(6):1884-9. PubMed ID: 9196090
    [Abstract] [Full Text] [Related]

  • 35. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart.
    Kobayashi T, Miyauchi T, Sakai S, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y.
    Am J Physiol; 1999 Apr 10; 276(4):H1197-206. PubMed ID: 10199843
    [Abstract] [Full Text] [Related]

  • 36. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure.
    Zolk O, Quattek J, Sitzler G, Schrader T, Nickenig G, Schnabel P, Shimada K, Takahashi M, Böhm M.
    Circulation; 1999 Apr 27; 99(16):2118-23. PubMed ID: 10217651
    [Abstract] [Full Text] [Related]

  • 37. Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1.
    Fink CA, Moskal M, Firooznia F, Hoyer D, Symonsbergen D, Wei D, Qiao Y, Savage P, Beil ME, Trapani AJ, Jeng AY.
    Bioorg Med Chem Lett; 2000 Sep 04; 10(17):2037-9. PubMed ID: 10987444
    [Abstract] [Full Text] [Related]

  • 38. Endothelin-converting enzyme inhibitors: current status and perspectives.
    Löffler BM.
    J Cardiovasc Pharmacol; 2000 Sep 04; 35(4 Suppl 2):S79-82. PubMed ID: 10976788
    [Abstract] [Full Text] [Related]

  • 39. Effects of a selective neutral endopeptidase and a nonselective neutral endopeptidase/endothelin-converting enzyme inhibitor on lipopolysaccharide-induced endotoxaemia in anaesthetized Sprague-Dawley rats.
    Pham D, Jeng AY, Escher E, Sirois P, Battistini B.
    J Cardiovasc Pharmacol; 2000 Nov 04; 36(5 Suppl 1):S362-6. PubMed ID: 11078421
    [Abstract] [Full Text] [Related]

  • 40. Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm.
    Lin CL, Winardi W, Jeng AY, Kwan AL.
    Neurol Res; 2006 Oct 04; 28(7):721-9. PubMed ID: 17164035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.